Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic Diseases - EP1830843

The patent EP1830843 was granted to Boehringer Ingelheim on Nov 7, 2012. The application was originally filed on Dec 21, 2005 under application number EP05823930A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP1830843

BOEHRINGER INGELHEIM
Application Number
EP05823930A
Filing Date
Dec 21, 2005
Status
Opposition Rejected
Grant Date
Nov 7, 2012
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZAug 7, 2013BEST -

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO0056710
INTERNATIONAL-SEARCH-REPORTWO0127081
INTERNATIONAL-SEARCH-REPORTWO2004013099
INTERNATIONAL-SEARCH-REPORTWO2004017948
INTERNATIONAL-SEARCH-REPORTWO9640116
INTERNATIONAL-SEARCH-REPORTWO9915500
INTERNATIONAL-SEARCH-REPORTWO9962882

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents